BREA, Calif., April 10, 2018 /PRNewswire/ — Beckman Coulter Diagnostics today announced commercialization of its Access Sensitive Estradiol in the U.S., with simultaneous commercial availability of its assay in the majority of global markets. The test is commonly ordered for detecting…
